Combined Active Treatment in Type 2 Diabetes with NASH

NCT04639414 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Non-alcoholic Steatohepatitis (NASH)
Non-alcoholic Fatty Liver Disease (NAFLD)

Interventions

DRUG: Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector
DRUG: Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide
DRUG: Placebo matching empagliflozin and placebo pen injector matching semaglutide

Sponsor

German Diabetes Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]